Gross margin from €198,200 to €102,535Result from €188,863 to €102,842Merger: absorbed by Etixx Sports28-12Merger proposal: to be absorbed by Etixx Sports NV16-10Equity from €288,863 to €391,704Debts from €379,154 to €479
Key points
from the 2018 annual accounts, the last ones filed
Merger proposal: to be absorbed by Etixx Sports NV
Permanent representatives: Name hiddenVisible after signing in, Hidden nameVisible after signing in, Name after signing inVisible after signing in and Name hiddenVisible after signing in · Board meeting of 24-08-2018 · Gazette deed
Incorporation
Founding capital of €100,000, 1,000 shares · Founder: Hidden nameVisible after signing in · Appointment: Name after signing inVisible after signing in (manager) · Gazette deed
Absorbed by Etixx Sportsmerger by absorption, December 2018
Activity
“De handel onder al zijn vormen (groot- en kleinhandel, aan- en verkoop, import en…” (deed in Dutch)From the articles, 5 activitiesNo NACE code in the KBO yet
The company number of MD PHARMA is 0643.996.361. The VAT number is the same number with BE in front: BE 0643.996.361.
What is the legal form of MD PHARMA?
Legal form of MD PHARMA: BVBA.
Is MD PHARMA still active?
No. MD PHARMA is inactive in the KBO register.Company details
What is the turnover of MD PHARMA?
The turnover in financial year 2018 is ≈ €260,000. This figure is estimated from the gross margin of €102,535 and 1,653 comparable companies of the same size. It probably lies between €160,000 and €490,000. It is a rough estimate.Financials
Is MD PHARMA profitable?
In financial year 2018, MD PHARMA made a profit of €102,842.
Where can I find the annual accounts of MD PHARMA?
MD PHARMA filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2018.